Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-09-23

FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)

View source ↗

Summary

FDA approved a supplemental application for ZOLADEX (goserelin) submitted by TerSera Therapeutics LLC. The approval updates the label to reflect new information…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoladex (goserelin)

Snippet

SUPPL AP for ZOLADEX (GOSERELIN)